#USA #Philadelphia #Clinical Research #Conference Forum #Patient Enrollment

The Conference Forum's Partnerships with Sites Summit

The Conference Forum has recently announced a highly anticipated event, the Partnerships with Sites Summit, scheduled for September 15, 2025. This summit aims to bring together vital players in the clinical research field at the Loews Philadelphia Hotel, where pharmaceutical companies, contract research organizations (CROs), and clinical sites will gather. The primary goal is to address the critical issue of patient enrollment in clinical studies, a challenge that has become increasingly complex as trial protocols evolve.

Valerie Bowling, Executive Director of the Conference Forum, stated, "The time is now, as sites face more burden, as protocols get more complex and as demands for trials increase." The summit seeks to identify ways to build a sustainable partnership ecosystem, ultimately enhancing patient access and increasing enrollment rates in clinical research.

Understanding the Need for Change

Clinical sites are currently experiencing heightened pressure, with the complexities of trials leading to increased workloads and strained resources. The Partnerships with Sites Summit aims to break down these challenges, focusing on essential strategies and system improvements necessary for revitalizing the ecosystem and positioning sites for success in patient enrollment.

The event will feature a diverse array of stakeholders who will engage in open discussions aimed at crafting an infrastructure conducive to efficient patient recruitment and retention. Among the showcasing leaders are major pharmaceutical companies such as Merck, Biogen, Boehringer Ingelheim, Eli Lilly & Co., and Endo, which highlights the collaborative nature of this initiative.

Key Topics of Discussion

The summit will cover a variety of pertinent topics, including:

• - Building Systems and Relationships for Enrollment: Exploring ways to improve partnerships that directly influence enrollment success.
• - Addressing Site Burdens and Operational Efficiency: Discussing methods to alleviate the pressures faced by clinical sites through optimized operations.
• - Creating Sustainable Partnerships: Developing long-lasting relationships between sites, pharmaceutical companies, and CROs to foster mutual success.
• - Rebuilding Trust Beyond Transactions: Strategies to move past mere transactional interactions towards trust-based collaborations.
• - Involving Sites in Protocol Feasibility: Engaging clinical sites earlier in the trial design process.
• - Bridging the Technology Gap: Addressing technological disparities and workflows that impact recruitment and retention.
• - Current Trends in the Trial Site Ecosystem: Analyzing trends that affect the operational landscape of clinical trials.

Kate Woda, Senior Director of Partnerships with Sites, emphasizes the summit's goal to equip all stakeholders with tools and insights to successfully recruit the right patients for suitable trials at the appropriate time.

Following Events

Just after this summit, those interested in further innovations in clinical research can participate in DPHARM Disruptive Innovations to Modernize Clinical Research, held on September 16-17, at the same venue. This will further enrich discussions surrounding the strategic evolution of clinical research practices.

Conclusion

The Partnerships with Sites Summit represents a critical step towards enhancing patient enrollment strategies within clinical trials. By engaging key stakeholders and fostering meaningful relationships, the Conference Forum aims to innovate and streamline the process of patient recruitment in clinical research, ensuring trials are not only effective but also accessible for potential participants.

For more information on the summit and to secure your participation, visit partnershipswithsites.com.